Biomind Labs Inc. (BMNDF)
OTCMKTS · Delayed Price · Currency is USD
0.1463
+0.0705 (93.01%)
Jul 29, 2026, 3:28 PM EST
Biomind Labs Market Cap
Biomind Labs has a market cap or net worth of $11.35 million as of July 30, 2026. Its market cap has increased by 46.30% in one year.
Market Cap
11.35M
Enterprise Value
12.12M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.15
ChartMarket Cap Chart
Since July 27, 2021, Biomind Labs's market cap has decreased from 18.69M to 11.35M, a decrease of -39.28%. That is a compound annual growth rate of -9.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 11.35M | 28.33% |
| Dec 30, 2025 | 8.84M | -67.68% |
| Dec 19, 2022 | 27.36M | 46.40% |
| Jul 27, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galera Therapeutics | 16.25M |
| Finch Therapeutics Group | 15.42M |
| Inhibitor Therapeutics | 13.90M |
| Anebulo Pharmaceuticals | 13.46M |
| Synlogic | 13.10M |
| Zeo ScientifiX | 13.05M |
| Brainstorm Cell Therapeutics | 9.88M |
| Curative Biotechnology | 8.58M |